glp-1 side effects Receptor Agonists GLP-1s can transform your health—but

JAK inhibitors are highly effective drugs, but their use is often discussed in the context of cardiovascular safety concerns that largely come from rheumatoid arthritis populations

110 However, their impact on metabolic health remains a concern

Davies M, Pieber TR, Hartoft-Nielsen M-L, Hansen OKH, Jabbour S, Rosenstock J

thus, dose reduction strategies (e.g., taking 100 mcg from Monday to Saturday but skipping Sunday) may not have been accurately captured

Novos obesity version of semaglutide (at a higher dose) is marketed as Wegovy and was approved in 2021

Taken together with the observation of elevated lipase concentrations in patients treated with GLP-1 receptor agonists [9], it is conceivable that these drugs exert some effects on the exocrine pancreas, although a specific mechanism of action has not yet been identified, and the presence of GLP-1 receptors in pancreatic exocrine cells is still a matter of dispute [10]